Amneal Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMNEAL PHARMS, and what generic and branded alternatives to AMNEAL PHARMS drugs are available?
AMNEAL PHARMS has two hundred and sixteen approved drugs.
There are six tentative approvals on AMNEAL PHARMS drugs.
Drugs and US Patents for Amneal Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal Pharms | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 202202-003 | Mar 4, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amneal Pharms Co | PREGABALIN | pregabalin | CAPSULE;ORAL | 209743-007 | Jul 19, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amneal Pharms | NIACIN | niacin | TABLET, EXTENDED RELEASE;ORAL | 203578-001 | Jul 24, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amneal Pharms | MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 205107-002 | Sep 4, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for AMNEAL PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
Similar Applicant Names
Here is a list of applicants with similar names.